Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2024-04-16

Thrombosis and disabilities

Obiettivo

The European Concerted Action on Thrombosis and Disabilities (ECAT) is a collaborative multicentre effort to elucidate the role of thrombotic processes in the pathogenesis of various arterial and venous vessel diseases.

The major activities of the ECAT are focused on finding laboratory assays which are able to predict which persons are at risk of suffering thrombosis. If such assays are available, more insight into the pathogenetic mechanisms of thrombosis may be obtained, individuals at high risk may be identified and, ultimately, effective measures can be developed for intervention on high-risk patients. The assays being tested are based on factors playing a role in processes underlying thrombosis: these factors are derived from vascular endothelium, blood platelets, the coagulation and fibrinolysis systems. Prediction of thrombotic events by assays presupposes the existence of a prethrombotic state in the blood circulation.
A European study has been set up to elucidate the role of thrombotic processes in the pathogenesis of various arterial and venous vessel diseases. This involved analysis of the results of haemostasis assays for important in thrombus formation, and correlation to subsequent clinical events. It was found that patients at risk of a coronary event had increased levels of the haemostatic fators fibrinogen and von Willebrand factor (vWF) and a depressed fibrinolytic activity, mainly indicated by increased t-plasminogen activator (t-PA) antigen which is linked to low t-PA activity. Also patients with blood group A and B are more prone to coronary events than blood group O which may be explained by the occurrence of blood group A and B structures in the vWF, indicating a genetic determinant.
The acute phase protein C-reactive protein (CRP) was increased in patients at risk of a coronary event, but remained below concentrations of 10 mg/l. This important finding show that CRP is a sensitive marker to follow the progression of atherosclerosis. It explains partially the increase of levels of fibrinogen, which is known to be an acute phase reactant. It also explains previously reported risk indicators of a myocardial infarction such as increased erythrocyte sedimentation rate (ESR) and increased white blood cell count.
Results obtained with coronary angiography support the role of fibrinogen in the progression of atherosclerosis in that patients with stenoses had higher levels of this factor.
The assays indicated the risk independent of other, known risk factors. They do not correlate with total cholesterol in plasma, which was only weakly predictive for a myocardial infarction in patients with angina pectoris.
It is suggested that risk scores for patients with angina pectoris should now incorporate the levels of fibrinogen, vWF and t-PA antigen.

Campo scientifico (EuroSciVoc)

CORDIS classifica i progetti con EuroSciVoc, una tassonomia multilingue dei campi scientifici, attraverso un processo semi-automatico basato su tecniche NLP. Cfr.: Il Vocabolario Scientifico Europeo.

È necessario effettuare l’accesso o registrarsi per utilizzare questa funzione

Programma(i)

Programmi di finanziamento pluriennali che definiscono le priorità dell’UE in materia di ricerca e innovazione.

Argomento(i)

Gli inviti a presentare proposte sono suddivisi per argomenti. Un argomento definisce un’area o un tema specifico per il quale i candidati possono presentare proposte. La descrizione di un argomento comprende il suo ambito specifico e l’impatto previsto del progetto finanziato.

Dati non disponibili

Invito a presentare proposte

Procedura per invitare i candidati a presentare proposte di progetti, con l’obiettivo di ricevere finanziamenti dall’UE.

Dati non disponibili

Meccanismo di finanziamento

Meccanismo di finanziamento (o «Tipo di azione») all’interno di un programma con caratteristiche comuni. Specifica: l’ambito di ciò che viene finanziato; il tasso di rimborso; i criteri di valutazione specifici per qualificarsi per il finanziamento; l’uso di forme semplificate di costi come gli importi forfettari.

CON - Coordination of research actions

Coordinatore

TNO Gaubius Institute
Contributo UE
Nessun dato
Indirizzo
PO Box 430
2300 AK Leiden
Paesi Bassi

Mostra sulla mappa

Costo totale

I costi totali sostenuti dall’organizzazione per partecipare al progetto, compresi i costi diretti e indiretti. Questo importo è un sottoinsieme del bilancio complessivo del progetto.

Nessun dato
Il mio fascicolo 0 0